跳至主要内容
临床试验/CTRI/2023/03/050954
CTRI/2023/03/050954招募中2 期

In Vitro and Clinical evaluation of Aamlaki Emblica officinalis and Daruharidra Berberis aristata in combined form in comparison with Tab Cefixime in the Management of Garbhini Mutrakrichra wsr to Urinary Tract Infection in Pregnancy

PARUL INSTITUTE OF AYURVED0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Lakshanas of Garbhini Mutrakrichra like Sadahamutrata, Sarujamutrata, Muhur-muhurmutrata.
  • Symptoms of Lower UTI in pregnancy like dysuria, burning, frequency, urgency and strangury.
  • Both primi & multigravida in 2nd and 3rd trimester of Pregnancy.
  • Age group in between 18 to 35 years.
  • Laboratory investigations showing pus cells in urine ( >5 pus cells/HPF).

排除标准

  • Patients not willing for trial.
  • Patients suffering from medical illness like Poly-cystic kidneys, Hydronephrosis, Impaired renal functions, Malignancy of genito- urinary tract, Immuno-compromised patient.
  • Uncontrolled Hypertension, Gestational Diabetes and Anaemia ( <8gm %).
  • Complications of pregnancy like placental abnormalities.
  • Polyhydramnios
  • Bad obstetric history.

研究者

发起方
PARUL INSTITUTE OF AYURVED

相似试验